- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03391518
Evaluation of Blood Flow Regulation With Laser Speckle Flowgraphy
December 30, 2017 updated by: Augenabteilung Allgemeines Krankenhaus Linz
Evaluation of Blood Flow Regulation With Laser Speckle Flowgraphy in Patients With Normal Tension Glaucoma and Healthy Individuals.
The study includes Caucasian patients with diagnosis of normal tension glaucoma and age- and sex-matched healthy individuals.
Measurements of optic nerve head blood flow will be performed with laser speckle flowgraphy (LSFG).
Also, the intraocular pressure (IOP), systolic and diastolic blood pressure, heart rate (HR), mean arterial pressure (MAP) as well as ocular perfusion pressure (OPP) will be evaluated.
After baseline measurements individuals will be asked to ingest 800 ml of water in less than five minutes.
Measurements will be repeated after 15, 30 and 45 minutes.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
18
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Oberösterreich
-
Linz, Oberösterreich, Austria, 4021
- AKH Linz
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- presence of glaucomatous optic disc changes in biomicroscopy and visual field defects or abnormal circumpapillary retinal nerve fibre layer (RNFL) thinning (evaluated by OCT as defined by the on-board software)
- IOP ≤ 21mmHg without therapy
- normal open angle in a gonioscopic examination
- age > 40 years
Exclusion Criteria:
- IOP > 21 mmHg in patients' history
- ametropia > 6 diopters
- cataract with severity greater than grade 2 of the lens opacities classification system (LOCS) classification
- presence of corneal opacities
- uncontrolled hypertension with systolic blood pressure (SBP) > 165mmHg and/or diastolic blood pressure (DBP) > 100mmHg
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in ONH blood flow induced by water drinking test
Time Frame: baseline, after 15, 30 and 45 minutes
|
ONH blood flow evaluated by laser speckle flowgraphy
|
baseline, after 15, 30 and 45 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 5, 2017
Primary Completion (Actual)
December 4, 2017
Study Completion (Anticipated)
January 31, 2018
Study Registration Dates
First Submitted
December 30, 2017
First Submitted That Met QC Criteria
December 30, 2017
First Posted (Actual)
January 5, 2018
Study Record Updates
Last Update Posted (Actual)
January 5, 2018
Last Update Submitted That Met QC Criteria
December 30, 2017
Last Verified
December 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- LSFG_WDT
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Low Tension Glaucoma
-
Qlaris Bio, Inc.Not yet recruitingGlaucoma | Normal Tension Glaucoma (NTG) | Low-Tension Glaucoma, Bilateral | Low-Tension Glaucoma, Unspecified EyeKorea, Republic of, Philippines
-
Technische Universität DresdenRecruitingGlaucoma | Glaucoma, Open-Angle | Glaucoma, Angle-Closure | Glaucoma, Low TensionGermany
-
University of North Carolina, Chapel HillSensimed AGCompletedNormal-Tension GlaucomaUnited States
-
Qlaris Bio, Inc.CompletedNormal Tension Glaucoma (NTG)United States
-
Technische Universität DresdenCompletedNormal Tension Glaucoma | High Tension Glaucoma
-
Intuor Technologies, Inc.Not yet recruitingOcular Hypertension | Glaucoma | Normal Tension GlaucomaUnited States
-
Salus UniversityNot yet recruitingNormal Tension GlaucomaUnited States
-
Merck Sharp & Dohme LLCCompleted
-
The Catholic University of KoreaSeoul St. Mary's HospitalCompletedNormal Tension GlaucomaKorea, Republic of
-
Seoul National University HospitalUnknownNormal Tension GlaucomaKorea, Republic of
Clinical Trials on Water drinking test
-
University of ManitobaNot yet recruitingNormal Tension Glaucoma
-
Wills EyeCompleted
-
Lithuanian University of Health SciencesKlaipėda UniversityCompletedDysphagia | Swallowing DisordersLithuania
-
The Novo Nordisk Foundation Center for Basic Metabolic...CompletedHealthy Participants
-
University of ManitobaCompleted
-
University of North Carolina, Chapel HillNational Institute of Dental and Craniofacial Research (NIDCR); Tulane UniversityRecruiting
-
Changi General HospitalELO Water Pte. Ltd.CompletedDiabetes MellitusSingapore
-
Menekşe Nazlı AKERCompletedPremenstrual SyndromeTurkey
-
Vanderbilt University Medical CenterEnrolling by invitation
-
ALI KAMAL M. SAMICompleted